SCHEMBL13638501

SCHEMBL13638501

C=C1CC(Nc2nccc(-c3ccc(-c4cccnc4)s3)n2)CC(C)(C)N1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 6/20 0.41
HDAC6 Q9UBN7 4/20 0.41
HDAC1 Q13547 3/20 0.41
ROCK2 O75116 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
ABL1 P00519 6/20 0.38
PRKCA P17252 4/20 0.38
PRKCD Q05655 3/20 0.38
EGFR P00533 3/20 0.38
BCR P11274 5/20 0.36
CYP2E1 P05181 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2A6 P11509 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2B6 P20813 1/20 0.36
CYP2C19 P33261 1/20 0.36
RET P07949 2/20 0.35
PRKD3 O94806 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13638286 0.90 ROCK2 (0.35) HDAC8HDAC6HDAC1ROCK2CDK1
SCHEMBL14612808 0.89 HDAC8 (0.44) HDAC8HDAC6HDAC1ROCK2HDAC7
SCHEMBL14612851 0.87 CDK5 (0.37) HDAC8HDAC6HDAC1ROCK2ABL1
SCHEMBL3477790 0.87 ROCK2 (0.45) HDAC8HDAC6HDAC1ROCK2HDAC7
SCHEMBL13638302 0.86 IKBKB (0.46) HDAC8HDAC6CDK1CCNB1AKT3
SCHEMBL14612849 0.86 IKBKB (0.35) HDAC8CDK1CCNB1CCNA2CCNE1
SCHEMBL13638420 0.86 KDM4E (0.38) RETPRKACACCNB2CDK1CCNB1
SCHEMBL14612878 0.86 MKNK1 (0.44) HDAC8JAK2MKNK2CCNE2CCNA2
SCHEMBL14612804 0.85 MKNK1 (0.39) HDAC8GSK3BMKNK2
SCHEMBL13638470 0.85 CHEK1 (0.34) HDAC8HDAC6HDAC1HDAC7HDAC9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7615562-B2 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents NOVARTIS AG (CH) 2009-11-10 US disclosed